NorthStar and IBA expand collaboration for Tc-99m availability

NorthStar Medical Radioisotopes and IBA expanded their collaboration to enable global availability of technetium-99m (Tc-99m) using NorthStar's non-uranium based Mo-99 produced with IBA accelerators. The expansion builds on an existing contract for up to eight Rhodotron accelerators.

“The collaboration enables companies outside of the United States to access the Tc-99m Generation Systems that utilize NorthStar's proprietary non-uranium based Mo-99 produced using IBA's accelerators and beamlines.”biospace.com

• 1 source
• biospace.comNorthStar Medical Radioisotopes and IBA Expand Collaboration to Enable Global Availability of Diagnostic Radioisotope Technetium-99m (Tc-99m) - BioSpaceGabrielle MassonMar 8, 2021

Summarized from public sources; check the original articles before acting on it.